Pace S S - OmicsDI

Show results for

Unknown (2160)
Transcriptomics (96)
Proteomics (39)
Genomics (15)
Metabolomics (9)
Clinical (3)
Other (2)
Models (1)

Organisms

Homo sapiens (29)
Mus musculus (29)
Escherichia coli (14)
Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 (4)
Helicobacter pylori (4)
Rattus norvegicus (4)
Arabidopsis thaliana (4)
Saccharomyces cerevisiae (3)
Geobacter sulfurreducens PCA (2)
Xylella fastidiosa (2)
Schizosaccharomyces pombe (2)
Bacillus subtilis (2)
Salmonella enterica subsp. enterica serovar Typhimurium (2)
Escherichia coli str. K-12 substr. MG1655 (2)
Veillonella parvula DSM 2008 (1)
Staphylococcus xylosus (1)
Mycobacterium tuberculosis str. Erdman = ATCC 35801 (1)
Escherichia coli O08 (1)
Shewanella piezotolerans WP3 (1)
Porphyromonas gingivalis ATCC 33277 (1)
Leptospira interrogans (1)
Nitrosomonas europaea ATCC 19718 (1)
Shewanella oneidensis MR-1 (1)
Vulpes vulpes (1)
Neisseria gonorrhoeae (1)
Synechocystis sp. PCC 6803 (1)
Mytilus edulis (1)
Neisseria meningitidis MC58 (1)
Pan troglodytes (1)
Pan paniscus (1)

Organisms

Mus musculus (4)
Amblyomma maculatum (1)
Streptococcus mutans (1)

Repository

biostudies-arrayexpress (95)
pride (28)
ENA (11)
MetaboLights (8)
MassIVE (7)
geo (6)
jPOST (4)
BioModels (1)
EGA (1)
GNPS (1)

Tissue

Cell culture (12)
Myotube (5)
Skeletal muscle (3)
Brain (2)
Embryonic stem cell (2)
Epithelial cell (2)
Heart (2)
Skeletal muscle myoblast (2)
Early embryonic cell (1)
Epiblast (1)
Permanent cell line cell (1)
Plant cell (1)
Skeletal muscle cell line (1)
Small intestine epithelium (1)
Spinal cord (1)
Whole body (1)

Disease

Breast cancer (2)
Type 2 diabetes mellitus (2)
Chicken Anaemia Virus infected (1)
27, C19 27, ICD-10-MC (1)
Colorectal/Bowel Cancer (1)
Multi-pathological condition. According with Working Group of the Sociedad Española de Medicina Interna (SEMI), a patients are defined as multi-pathological or polypathological when they have chronic diseases that belong to two or more of the eight next categories:-Category A: NYHA heart failure class II (slight limitation of physical activity, in which ordinary physical activity causes dyspnea, angina, fatigue or palpitations). Ischemic heart disease.- Category B: Vasculitis and systemic autoimmune diseases. Chronic kidney disease defined by elevated creatinine (>1.4 mg/dL in men or >1.3 mg/dL in women) or proteinuria (albumin/creatinine ratio >300 mg/g, microalbuminuria >3mg/dL in urine sample or albumin >300 mg/day in 24-hour urine, for 3 months).- Category C: Chronic respiratory disease classified as MCR grade 2 (unable to keep the pace of another person of the same age (1)
Alzheimer's disease 1 (1)
Cardiovascular system disease (1)
Cervix carcinoma (1)
Disease free (1)

Technology Type

Mass Spectrometry (28)
Shotgun proteomics (15)
Bottom-up proteomics (10)
Mass spectrometry (7)
Data-dependent acquisition (4)
Gel-based experiment (2)
Mass spectrometry assay (1)
Affinity proteomics (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Data-independent acquisition (1)
DiaPASEF (1)
SWATH MS (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (6)
Illumina HiSeq 2500 (4)
LTQ XL ETD (2)
Q Exactive HF-X (2)
ScanArray 5000 [PerkinElmer] (1)
BGISEQ-500 (1)
Illumina HiSeq 1500 (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 4000 (1)
NextSeq 500 (1)
LTQ FT (1)
MaXis (1)
LTQ XL (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion (1)
Orbitrap Fusion Lumos (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive (1)

Publication Date

2010 (16)
2020 (12)
2023 (12)
2015 (11)
2014 (11)
2016 (8)
2025 (7)
2022 (7)
2013 (7)
2012 (7)
2011 (7)
2024 (7)
2026 (6)
2009 (5)
2008 (5)
2007 (5)
2006 (5)
2021 (3)
2019 (3)
2005 (2)
2004 (1)
2018 (1)
2017 (1)

CHEBI ID

CHEBI:16359 (3)
CHEBI:28865 (3)
CHEBI:35038 (3)
CHEBI:139138 (2)
CHEBI:143745 (2)
CHEBI:143757 (2)
CHEBI:173703 (2)
CHEBI:182784 (2)
CHEBI:195271 (2)
CHEBI:27432 (2)
CHEBI:27997 (2)
CHEBI:30769 (2)
CHEBI:34494 (2)
CHEBI:34687 (2)
CHEBI:64563 (2)
CHEBI:73858 (2)
CHEBI:75342 (2)
CHEBI:80774 (2)
CHEBI:10136 (1)
CHEBI:116314 (1)
CHEBI:131342 (1)
CHEBI:1427 (1)
CHEBI:145227 (1)
CHEBI:15422 (1)
CHEBI:15603 (1)
CHEBI:15741 (1)
CHEBI:15781 (1)
CHEBI:15846 (1)
CHEBI:15978 (1)
CHEBI:16002 (1)

Metabolite Name

Cholic acid (3)
Tris(2-butoxyethyl) phosphate (3)
(2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8aR,9R,12aS,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid (2)
1-({[2-(2-furylmethyl)-5-methylpyrrolidinyl]amino}methylene)-7-[8-({[2-(2-fury lmethyl)pyrrolidinyl]amino}methylene)-1,6-dihydroxy-3-methyl-5-(methylethyl)-7 -oxo(2-naphthyl)]-3,8-dihydroxy-6-methyl-4-(methylethyl)naphthalen-2-one (2)
1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (2)
2,6-Di-tert-butyl-4-hydroxymethylphenol (2)
9(10)-EpOME (2)
Alpha-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid (2)
Dibutyl phthalate (DBP) (2)
Elaidic acid (2)
Lyso-PC(16:0) (2)
Monoolein (2)
NCGC00385123-01_C22H30O6_7b,9-Dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate (2)
Succinate (2)
Taurocholic acid (2)
(R)-4-((3R,4R,5S,8S,9S,10R,13R,14S,17R)-3,4-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
1,3,5-triprop-2-enyl-1,3,5-triazaperhydroine-2,4,6-trione (1)
1,4a-dimethyl-9-oxo-7-propan-2-yl-3,4,10,10a-tetrahydro-2H-phenanthrene-1-carboxylic acid (1)
1-(9Z-Octadecenoyl)-sn-glycero-3-phosphocholine (1)
1-Heptadecanoyl-sn-glycero-3-phosphocholine (1)
1-Hexadecanoyl-sn-glycerol (1)
1-Hexadecyl-sn-glycero-3-phosphocholine (1)
1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine (1)
1-Myristoyl-sn-glycero-3-phosphocholine (1)
1-Palmitoyl-2-myristoyl-sn-glycero-3-phosphocholine (1)
13(S)-HODE methyl ester (1)
13-Keto-9Z,11E-octadecadienoic acid (1)
16-Hydroxyhexadecanoic acid (1)
17(18)-EpETE (1)

First Public Date

2023 (3)
2026 (2)
2025 (1)
2024 (1)
2022 (1)
2020 (1)
2019 (1)
2018 (1)

Modelling Approach

Ordinary differential equation model (1)

Study status

Not yet recruiting (2)
Active, not recruiting (1)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (4)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg im Breisgau, Germany (2)
Institute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Auf´m Hennekamp 65, 40225 Düsseldorf, Germany (2)
Babraham institute (1)
CRUK Beatson Institute (1)
Cardiac Bioengineering group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia (1)
Center for Genomics and Systems Biology, New York University, New York, NY, US (1)
Centre for Proteome Research, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Crown Street, Liverpool, L69 7ZB, U.K (1)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and BIOSS Centre for Biological Signalling Studies, University of Freiburg (1)
Department of Molecular Cell Biology, Weizmann Institute of Science (1)
Department of Neuroscience, School of Medicine, University of Florida (1)
Department of Neuroscience, University of Florida (1)
Department of Neurscience, College of Medicine, University of Florida (1)
Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte-MG, Brazil. (1)
Hannover Medical School Institute of Toxicology Carl-Neuberg-Str. 1 30625 Hannover Germany (1)
Key laboratory of Plant Molecular Physiology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 10093, People’s Republic of China (1)
Laboratoire de Spectrométrie de Masse BioOrganique, Analytical Science department, IPHC, CNRS, Strasbourg University, UMR7178, Strasbourg, France (1)
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany (1)
Max Planck Institut for Molecular Biomedicine Bioanalytical Mass Spectrometry Röntgenstr. 20 48149 Münster Germany (1)
Ralf Reski Distinguished Professor Head, Chair Plant Biotechnology Faculty of Biology University of Freiburg Schaenzlestrasse 1 D-79104 Freiburg Germany (1)
Umea University (1)
V. L. Talrose Institute for Energy Problems of Chemical Physics, N. N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, 119334 Moscow, Russia (1)
V.L. Talrose Institute for Energy Problems of Chemical Physics, N.N. Semenov Federal Research Center of Chemical Physics, Russian Academy of Sciences, 119334 Moscow, Russia (1)

IsPrivate

False (1)

Classification

bacteria (1)

Study type

Transcription profiling by array (60)
RNA-seq of coding RNA (11)
Unknown experiment type (10)
Interventional (3)
ChIP-chip by tiling array (2)
Animal - High-throughput sequencing (2)
ChIP-chip by array (2)
Other (2)
ChIP-seq (2)
RNA-seq of coding RNA from single cells (2)
High-throughput sequencing (1)
DNA-seq (1)

Release Date

2022 (282)
2021 (267)
2023 (264)
2025 (253)
2024 (249)
2020 (176)
2019 (136)
2018 (108)
2017 (94)
2015 (71)
2016 (59)
2014 (58)
2013 (46)
2010 (36)
2012 (34)
2026 (32)
2011 (29)
2009 (20)
2007 (11)
2008 (10)
2006 (10)
2005 (2)
2004 (2)
2003 (2)
2002 (1)
2001 (1)
1999 (1)
1998 (1)

Location

Australia (1)
China (1)
Colombia (1)

Previous page
1 / 233
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 233
Next page

Sort by:

Relevance

Page size

Transcriptional responses of Escherichia coli to GSNO under defined chemostat conditions.

Escherichia coli strain MG1655 was grown in a New Brunswick Scientific Bioflow III Biofermentor under continuous culture (chemostat) conditions. Cells were grown in defined media containing 54 mM glycerol as the sole and limiting source of energy and carbon. The working volume was 1 litre, and the d...

ORGANISM(S): Escherichia coli

2010-06-10 | E-GEOD-2095 | biostudies-arrayexpress

Transcriptional responses of Anaerobically grown Escherichia coli to GSNO under defined chemostat conditions.

ORGANISM(S): Escherichia coli

2010-06-10 | E-GEOD-2129 | biostudies-arrayexpress

ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion [HTGTS]

The ATR kinase, which coordinates cellular responses to DNA replication stress, is also essential for the proliferation of normal unstressed cells. Although its role in the replication stress response is well defined, the mechanisms by which ATR supports normal cell proliferation remain elusive. Her...

ORGANISM(S): Mus musculus

2022-12-31 | GSE212195 | GEO

ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion [RNA-seq]

ORGANISM(S): Mus musculus

2022-12-31 | GSE212194 | GEO

ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion [CRISPR-Cas9 gRNA screen]

ORGANISM(S): Mus musculus

2022-12-31 | GSE214643 | GEO

Walking pace is inversely associated with risk of death and cardiovascular disease: The Physicians' Health Study.

Not available

S-EPMC6743067 | biostudies-literature

ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion.